Spero Therapeutics Stock Price History

SPRO Stock  USD 0.78  0.01  0.99%   
Below is the normalized historical share price chart for Spero Therapeutics extending back to November 02, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Spero Therapeutics stands at 0.78, as last reported on the 20th of March, with the highest price reaching 0.78 and the lowest price hitting 0.75 during the day.
IPO Date
2nd of November 2017
200 Day MA
1.1677
50 Day MA
0.8383
Beta
0.686
 
Covid
If you're considering investing in Spero Stock, it is important to understand the factors that can impact its price. Spero Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0699, which indicates the firm had a -0.0699 % return per unit of risk over the last 3 months. Spero Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Spero Therapeutics' Variance of 15.08, risk adjusted performance of (0.11), and Coefficient Of Variation of (726.90) to confirm the risk estimate we provide.
  
As of the 20th of March 2025, Common Stock Shares Outstanding is likely to grow to about 64 M, while Total Stockholder Equity is likely to drop about 84.2 M. . As of the 20th of March 2025, Price Earnings Ratio is likely to grow to 3.21, while Price To Sales Ratio is likely to drop 0.87. Spero Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0699

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsSPRO

Estimated Market Risk

 3.96
  actual daily
35
65% of assets are more volatile

Expected Return

 -0.28
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.07
  actual daily
0
Most of other assets perform better
Based on monthly moving average Spero Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Spero Therapeutics by adding Spero Therapeutics to a well-diversified portfolio.
Price Book
0.6367
Enterprise Value Ebitda
0.7464
Price Sales
0.3918
Shares Float
40.5 M
Wall Street Target Price
5

Spero Therapeutics Stock Price History Chart

There are several ways to analyze Spero Stock price data. The simplest method is using a basic Spero candlestick price chart, which shows Spero Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceJanuary 3, 20251.1
Lowest PriceMarch 11, 20250.74

Spero Therapeutics March 20, 2025 Stock Price Synopsis

Various analyses of Spero Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Spero Stock. It can be used to describe the percentage change in the price of Spero Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Spero Stock.
Spero Therapeutics Price Rate Of Daily Change 1.01 
Spero Therapeutics Price Daily Balance Of Power 0.25 
Spero Therapeutics Price Action Indicator 0.02 

Spero Therapeutics March 20, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Spero Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Spero Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Spero Stock and then apply it to test your longer-term investment strategies against Spero.

Spero Stock Price History Data

The price series of Spero Therapeutics for the period between Fri, Dec 20, 2024 and Thu, Mar 20, 2025 has a statistical range of 0.41 with a coefficient of variation of 12.45. The price distribution for the period has arithmetic mean of 0.88. The median price for the last 90 days is 0.86. The company had dividends distributed to its stock-holders on 17th of September 2013.
OpenHighLowCloseVolume
03/20/2025
 0.77  0.78  0.75  0.78 
03/19/2025 0.75  0.77  0.75  0.77  48,199 
03/18/2025 0.77  0.78  0.75  0.75  25,347 
03/17/2025 0.78  0.78  0.76  0.77  25,959 
03/14/2025 0.77  0.80  0.77  0.78  17,820 
03/13/2025 0.75  0.78  0.75  0.78  44,956 
03/12/2025 0.75  0.76  0.74  0.75  32,313 
03/11/2025 0.76  0.76  0.73  0.74  130,565 
03/10/2025 0.77  0.78  0.75  0.75  58,272 
03/07/2025 0.79  0.80  0.77  0.78  149,292 
03/06/2025 0.77  0.80  0.77  0.79  111,695 
03/05/2025 0.77  0.78  0.74  0.77  105,617 
03/04/2025 0.77  0.77  0.75  0.77  146,937 
03/03/2025 0.77  0.82  0.77  0.77  161,725 
02/28/2025 0.76  0.78  0.76  0.78  34,311 
02/27/2025 0.79  0.79  0.76  0.78  92,156 
02/26/2025 0.80  0.80  0.79  0.79  53,741 
02/25/2025 0.80  0.83  0.79  0.80  89,402 
02/24/2025 0.83  0.83  0.78  0.81  142,172 
02/21/2025 0.83  0.84  0.81  0.83  82,071 
02/20/2025 0.83  0.84  0.83  0.84  60,511 
02/19/2025 0.82  0.84  0.82  0.84  224,175 
02/18/2025 0.82  0.86  0.82  0.82  82,607 
02/14/2025 0.81  0.82  0.80  0.82  90,543 
02/13/2025 0.81  0.83  0.81  0.82  61,005 
02/12/2025 0.81  0.82  0.80  0.81  47,955 
02/11/2025 0.79  0.84  0.79  0.82  60,506 
02/10/2025 0.81  0.82  0.79  0.80  142,361 
02/07/2025 0.85  0.86  0.81  0.82  147,314 
02/06/2025 0.89  0.90  0.85  0.86  224,011 
02/05/2025 0.76  0.95  0.75  0.88  1,489,743 
02/04/2025 0.80  0.82  0.74  0.75  681,955 
02/03/2025 0.84  0.85  0.79  0.80  443,856 
01/31/2025 0.86  0.88  0.85  0.86  67,114 
01/30/2025 0.85  0.87  0.84  0.87  149,583 
01/29/2025 0.87  0.87  0.85  0.86  50,994 
01/28/2025 0.85  0.88  0.85  0.87  77,180 
01/27/2025 0.86  0.90  0.86  0.86  59,760 
01/24/2025 0.87  0.88  0.85  0.87  170,873 
01/23/2025 0.88  0.92  0.86  0.87  117,273 
01/22/2025 0.89  0.94  0.86  0.87  187,402 
01/21/2025 0.93  0.94  0.87  0.90  266,411 
01/17/2025 0.85  0.94  0.85  0.91  371,285 
01/16/2025 0.91  0.94  0.83  0.83  558,781 
01/15/2025 0.95  0.97  0.87  0.90  590,572 
01/14/2025 0.93  0.99  0.92  0.97  180,625 
01/13/2025 0.96  1.01  0.92  0.95  156,583 
01/10/2025 1.00  1.02  0.96  0.98  266,412 
01/08/2025 1.04  1.05  1.00  1.00  159,357 
01/07/2025 1.07  1.11  1.04  1.05  80,158 
01/06/2025 1.08  1.13  1.06  1.08  228,584 
01/03/2025 1.07  1.12  1.07  1.10  188,834 
01/02/2025 1.05  1.09  1.05  1.08  187,370 
12/31/2024 1.04  1.05  1.01  1.03  175,339 
12/30/2024 1.01  1.02  0.99  1.02  314,181 
12/27/2024 0.96  1.05  0.94  1.03  330,676 
12/26/2024 0.94  0.96  0.93  0.94  494,934 
12/24/2024 0.94  0.95  0.92  0.94  215,910 
12/23/2024 0.97  0.98  0.92  0.92  368,487 
12/20/2024 0.99  0.99  0.95  0.96  329,737 
12/19/2024 0.99  1.02  0.99  1.00  207,719 

About Spero Therapeutics Stock history

Spero Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Spero is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Spero Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Spero Therapeutics stock prices may prove useful in developing a viable investing in Spero Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding60.9 M64 M
Net Loss-41.8 M-43.9 M

Spero Therapeutics Quarterly Net Working Capital

82.53 Million

Spero Therapeutics Stock Technical Analysis

Spero Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Spero Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Spero Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Positions Ratings Now

   

Positions Ratings

Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module

Spero Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Spero Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Spero Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Spero to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Spero Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Spero Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Spero Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Spero Therapeutics Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Spero Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in Spero Stock, please use our How to Invest in Spero Therapeutics guide.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Spero Therapeutics. If investors know Spero will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Spero Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.753
Earnings Share
0.08
Revenue Per Share
1.984
Quarterly Revenue Growth
(0.47)
Return On Assets
(0.01)
The market value of Spero Therapeutics is measured differently than its book value, which is the value of Spero that is recorded on the company's balance sheet. Investors also form their own opinion of Spero Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Spero Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Spero Therapeutics' market value can be influenced by many factors that don't directly affect Spero Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Spero Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Spero Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Spero Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.